Human kidney thiopurine methyltransferase purification and biochemical properties

Lee C. Woodson, Richard M Weinshilboum

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

Thiopurine methyltransferase (TPMT) catalyzes the S-methylation of thiopurines and thio-pyrimidines. Human kidney TPMT was purified over 300-fold and its biochemical properties were determined. TPMT was "soluble" and had a molecular weight of approximately 36,000 daltons as estimated by gel filtration chromatography. The pH optimum of the purified TPMT was 6.7. "True" Km values for 6-mercaptopurine (6-MP) and S-adenosyl-l-methionine (SAM), the two cosubstrates for the reaction, were 0.30 mM and 2.7 μM respectively. "Apparent" Km values for 6-thioguanine and 2-thiouracil, two other methyl acceptor substrates, were 0.55 and 2.0 mM respectively. Aliphatic thiol compounds were either poor substrates for TPMT or were not methylated. S-Adenosyl-l-homocysteine was a competitive inhibitor of TPMT when the varied substrate was SAM, and 6-methylmercaptopurine was a noncompetitive inhibitor with respect to 6-MP. Purified TPMT was neither activated nor inhibited by 1 mM Ca2+ or Mg2+, but exposure to reagents such as N-ethylmaleimide and ethacrynic acid that interact with sulfhydryl groups inactivated the enzyme. Tropolone inhibited TPMT with a Ki of approximately 0.85 mM. Finally, human kidney TPMT activity could be distinguished from human kidney thiol methyltransferase (EC 2.1.1.9) activity on the basis of subcellular distribution, substrate specificity, kinetic characteristics and differential sensitivity to inhibitors.

Original languageEnglish (US)
Pages (from-to)819-826
Number of pages8
JournalBiochemical Pharmacology
Volume32
Issue number5
DOIs
StatePublished - Mar 1 1983

Fingerprint

thiopurine methyltransferase
Purification
Kidney
thiol S-methyltransferase
6-Mercaptopurine
Substrates
Methionine
Tropolone
Thiouracil
Ethacrynic Acid
Thioguanine
Pyrimidines
Ethylmaleimide
Methylation
Homocysteine
Substrate Specificity
Chromatography
Sulfhydryl Compounds

ASJC Scopus subject areas

  • Pharmacology

Cite this

Human kidney thiopurine methyltransferase purification and biochemical properties. / Woodson, Lee C.; Weinshilboum, Richard M.

In: Biochemical Pharmacology, Vol. 32, No. 5, 01.03.1983, p. 819-826.

Research output: Contribution to journalArticle

@article{999bad2bc6834f3ca951c0c753944227,
title = "Human kidney thiopurine methyltransferase purification and biochemical properties",
abstract = "Thiopurine methyltransferase (TPMT) catalyzes the S-methylation of thiopurines and thio-pyrimidines. Human kidney TPMT was purified over 300-fold and its biochemical properties were determined. TPMT was {"}soluble{"} and had a molecular weight of approximately 36,000 daltons as estimated by gel filtration chromatography. The pH optimum of the purified TPMT was 6.7. {"}True{"} Km values for 6-mercaptopurine (6-MP) and S-adenosyl-l-methionine (SAM), the two cosubstrates for the reaction, were 0.30 mM and 2.7 μM respectively. {"}Apparent{"} Km values for 6-thioguanine and 2-thiouracil, two other methyl acceptor substrates, were 0.55 and 2.0 mM respectively. Aliphatic thiol compounds were either poor substrates for TPMT or were not methylated. S-Adenosyl-l-homocysteine was a competitive inhibitor of TPMT when the varied substrate was SAM, and 6-methylmercaptopurine was a noncompetitive inhibitor with respect to 6-MP. Purified TPMT was neither activated nor inhibited by 1 mM Ca2+ or Mg2+, but exposure to reagents such as N-ethylmaleimide and ethacrynic acid that interact with sulfhydryl groups inactivated the enzyme. Tropolone inhibited TPMT with a Ki of approximately 0.85 mM. Finally, human kidney TPMT activity could be distinguished from human kidney thiol methyltransferase (EC 2.1.1.9) activity on the basis of subcellular distribution, substrate specificity, kinetic characteristics and differential sensitivity to inhibitors.",
author = "Woodson, {Lee C.} and Weinshilboum, {Richard M}",
year = "1983",
month = "3",
day = "1",
doi = "10.1016/0006-2952(83)90582-8",
language = "English (US)",
volume = "32",
pages = "819--826",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Human kidney thiopurine methyltransferase purification and biochemical properties

AU - Woodson, Lee C.

AU - Weinshilboum, Richard M

PY - 1983/3/1

Y1 - 1983/3/1

N2 - Thiopurine methyltransferase (TPMT) catalyzes the S-methylation of thiopurines and thio-pyrimidines. Human kidney TPMT was purified over 300-fold and its biochemical properties were determined. TPMT was "soluble" and had a molecular weight of approximately 36,000 daltons as estimated by gel filtration chromatography. The pH optimum of the purified TPMT was 6.7. "True" Km values for 6-mercaptopurine (6-MP) and S-adenosyl-l-methionine (SAM), the two cosubstrates for the reaction, were 0.30 mM and 2.7 μM respectively. "Apparent" Km values for 6-thioguanine and 2-thiouracil, two other methyl acceptor substrates, were 0.55 and 2.0 mM respectively. Aliphatic thiol compounds were either poor substrates for TPMT or were not methylated. S-Adenosyl-l-homocysteine was a competitive inhibitor of TPMT when the varied substrate was SAM, and 6-methylmercaptopurine was a noncompetitive inhibitor with respect to 6-MP. Purified TPMT was neither activated nor inhibited by 1 mM Ca2+ or Mg2+, but exposure to reagents such as N-ethylmaleimide and ethacrynic acid that interact with sulfhydryl groups inactivated the enzyme. Tropolone inhibited TPMT with a Ki of approximately 0.85 mM. Finally, human kidney TPMT activity could be distinguished from human kidney thiol methyltransferase (EC 2.1.1.9) activity on the basis of subcellular distribution, substrate specificity, kinetic characteristics and differential sensitivity to inhibitors.

AB - Thiopurine methyltransferase (TPMT) catalyzes the S-methylation of thiopurines and thio-pyrimidines. Human kidney TPMT was purified over 300-fold and its biochemical properties were determined. TPMT was "soluble" and had a molecular weight of approximately 36,000 daltons as estimated by gel filtration chromatography. The pH optimum of the purified TPMT was 6.7. "True" Km values for 6-mercaptopurine (6-MP) and S-adenosyl-l-methionine (SAM), the two cosubstrates for the reaction, were 0.30 mM and 2.7 μM respectively. "Apparent" Km values for 6-thioguanine and 2-thiouracil, two other methyl acceptor substrates, were 0.55 and 2.0 mM respectively. Aliphatic thiol compounds were either poor substrates for TPMT or were not methylated. S-Adenosyl-l-homocysteine was a competitive inhibitor of TPMT when the varied substrate was SAM, and 6-methylmercaptopurine was a noncompetitive inhibitor with respect to 6-MP. Purified TPMT was neither activated nor inhibited by 1 mM Ca2+ or Mg2+, but exposure to reagents such as N-ethylmaleimide and ethacrynic acid that interact with sulfhydryl groups inactivated the enzyme. Tropolone inhibited TPMT with a Ki of approximately 0.85 mM. Finally, human kidney TPMT activity could be distinguished from human kidney thiol methyltransferase (EC 2.1.1.9) activity on the basis of subcellular distribution, substrate specificity, kinetic characteristics and differential sensitivity to inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=0020640116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020640116&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(83)90582-8

DO - 10.1016/0006-2952(83)90582-8

M3 - Article

VL - 32

SP - 819

EP - 826

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 5

ER -